Embedding genetic testing in the metastatic prostate cancer pathway: understanding patient and physician perspectives
Understanding physicians' and patients' experiences with, and challenges surrounding, genetic testing for PCa may facilitate better clinical-management interactions.
Authors
- Sophie Barlow (ORCID: https://orcid.org/0000-0001-5604-1360)
- Jacob Skilling
- Katie Pascoe (ORCID: https://orcid.org/0000-0001-5742-4654)
- Jake Butcher
- Amanda Ribbands (ORCID: https://orcid.org/0000-0001-9819-8737)
- Ruhee Jain
- Andrea Stevens
Institutions
- Adelphi Group (United Kingdom) (GB)
- Johnson & Johnson (Israel) (IL)
Publication Details
- Journal
- Future Oncology
- Published
- 2025-10-31
- DOI
- https://doi.org/10.1080/14796694.2025.2577337
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00